WASHINGTON (Aug. 13, 2020) — Fingolimod, an FDA-approved immunosuppressive drug used to treat multiple sclerosis flare-ups, may be used to block HIV infection and reduce the latent reservoir. Researchers at the George Washington University (GW) published their novel findings in PLOS Pathogens.
MS Drug May be Used to Inhibit HIV Infection and Reduce Latent Reservoir
Latest News
Congratulations to Paprika Berry, Pedro Gazzinelli and Jada Covington (a PhD student in the IBS program - former rotating student) from the Gazzinelli lab, for advancing to the Top 5 in the GW New Venture Competition in the Healthcare track! Their innovative project, Weigh2Dose, also earned them…
Researchers at the George Washington University (GW) School of Medicine and Health Sciences (SMHS), in collaboration with colleagues in France and Germany, have developed a model organism from a genetically modified parasitic worm to better study neglected tropical disease.
Brita Ostermeier from the Maggirwar Lab awarded "Young Investigator Award for the Most Outstanding Oral Presentation" at the Society on Neuroimmune Pharmacology Conference